Please assess the completion status of the following clinical trial:

Trial Title: Effects of Endoscopic Sinus Surgery for Chronic Sinusitis on Asthma Control

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Inclusion criteria: General~  1. 18 years of age or older~ 2. Women need one of the following: negative pregnancy test or suitable birth control or post-menopausal status~ 3. Informed consent and ability to comply with study procedures~ 4. Patients must meet inclusion criteria for both asthma and sinus disease.~Inclusion criteria: Asthma~In order to qualify for the 6 week run-in, patients must have poorly controlled asthma as defined by the following criteria:~1. Diagnosis of asthma confirmed either by demonstrating a positive methacholine challenge test (defined as a decrease in FEV1 by at least 20%, following administration of 8mg or less of inhaled methacholine) or a positive bronchodilator response (defined as a change from base line of \>12% and at least 200ml in either FEV1 or FVC, following administration of a short-acting, inhaled bronchodilator).~2. Either:~   * Asthma Control Questionnaire score \> 1.5 or~  * Use of inhaled rescue ß-agonist \>/= 16 puffs per week (excluding use as a pre-medication for exercise; 1 nebulizer treatment = 2 puffs of inhaler) at any time during the past month or~  * \>1 hospitalization or unscheduled MD visit in the past 6 months for asthma symptoms or~  * \>1 course of oral steroid use in past 6 months or~  * \> 2 weeks of systemic steroids in last 6 months.~Exclusion Criteria:~1. Current smokers or those with at least a 10 pack-year smoking history~2. Presence of any concurrent diseases that, in the investigator's opinion, would interfere with participation in the study or that might put the participant at risk

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Medical therapy (Type: PLACEBO_COMPARATOR): Patients undergo surgery 6 months after randomization
- Surgery (Type: EXPERIMENTAL): Patients undergo surgery at time of randomization

Based on this trial design, predict the completion outcome and termination type (if applicable).